Ā | Control group | NDPN group | SDPN group | DPN group |
---|---|---|---|---|
n (M/F) | 42(23/19) | 29(19/10) | 26(15/11) | 34(23/11) |
Age (/year) | 52.3āĀ±ā5.6 | 52.9āĀ±ā7.6 | 51.3āĀ±ā12.8 | 51.6āĀ±ā13.1 |
BMI(kg/m2) | 22.5āĀ±ā2.1 | 23.5āĀ±ā2.6 | 23.6āĀ±ā2.3 | 23.1āĀ±ā3.1 |
TG(mmol/l) | 1.7āĀ±ā1.1 | 1.9āĀ±ā1.3 | 1.8āĀ±ā0.8 | 1.8āĀ±ā1.5 |
HDL-C(mmol/l) | 1.3āĀ±ā0.4 | 1.1āĀ±ā0.3 | 1.2āĀ±ā0.1 | 1.3āĀ±ā0.5 |
LDL-C(mmol/l) | 2.9āĀ±ā1.1 | 3.0āĀ±ā1.2 | 3.2āĀ±ā1.0 | 3.4āĀ±ā1.1 |
TC(mmol/l) | 4.6āĀ±ā1.4 | 4.7āĀ±ā1.2 | 4.7āĀ±ā1.0 | 5.2āĀ±ā1.4 |
UA(umol/L) | 300.1āĀ±ā88.2 | 355.7āĀ±ā106.5 | 308.9āĀ±ā64.4 | 325.3āĀ±ā89.7 |
HbA1c(%) | 5.6āĀ±ā0.4 | 8.6āĀ±ā2.1# | 8.7āĀ±ā2.1# | 10.9āĀ±ā2.5#** |
FBG(mmol/L) | 5.1āĀ±ā0.5 | 8.7āĀ±ā3.2# | 8.9āĀ±ā3.0# | 10.9āĀ±ā4.9#* |
Illness duration(/year) | - | 4.2āĀ±ā4.5# | 4.5āĀ±ā5.1# | 7.3āĀ±ā5.5#* |
Hypertension (%) | - | 14 (48.27) | 13 (50.00) | 18 (52.94) |
CAD (%) | - | 3 (10.34) | 3 (11.54) | 4 (11.76) |
CVD (%) | - | 2 (6.89) | 2 (7.69) | 3 (8.82) |